Inverness Medical Innovations Inc.

Ron Zwanziger has been a director since November 2006. Mr. Zwanziger has served as Chairman and Chief Executive Officer of Inverness Medical Innovations, Inc. since 2001. From 1992 to 2001, he served in the same capacity at Inverness Medical Technology, Inc., a consumer focused company he founded that developed proprietary technologies and manufacturing processes. From 1981 to 1991, Mr. Zwanziger was Chairman, CEO and Founder of Medisense, Inc. Mr. Zwanziger received his undergraduate degree from Imperial College and an MBA from the Harvard Business School.

Geoffrey Jenkins is Vice President of Worldwide Operations. He has over twenty-five years of operational experience in professional and consumer healthcare companies. In 2000, he co-founded UV-Solutions, LLC, a product development company specializing in flash-based germicidal ultra violet sterilization technology. Prior to UV-Solutions, Mr. Jenkins joined MDI Instruments, Inc. as Chief Operating Officer and was appointed President in 1998. MDI Instruments developed and marketed both consumer and professional diagnostic devices for the early detection of ear infections (Otitis Media). The company was acquired by Beckton Dickinson in 1999. Geoff served as Vice President of Operations for MediSense, Inc., an international developer, manufacturer, and marketer of professional and consumer diagnostics. He was responsible for MediSense's domestic and international operations. Geoff joined MediSense as an early stage start-up in 1984 and managed the development of the company's blood glucose monitors.

Hilde Eylenbosch, M.D., has served as Vice President of the Company and President of our Consumer Diagnostics strategic business unit since April 2005. Prior to this, Dr Eylenbosch was Vice President Consumer Marketing, a position she held since October 2004, and Vice President of International Women's Health since November 2001. Dr. Eylenbosch served in the same capacity for our predecessor company, Inverness Medical Technology, from August 2001 until that company was acquired by Johnson & Johnson in November 2001. Prior to that she held various positions at Inverness Medical Technology, including Director of U.S. Women's Health from September 1998 through October 2000. When she joined Inverness Medical Technology in January 1995, Dr Eylenbosch was responsible for marketing that company's women's health products in Europe. Before joining Inverness Medical Technology, Dr Eylenbosch was employed by Synthelabo, a French pharmaceutical company, where she held various marketing positions.

Jerry McAleer, Ph.D has served as our Vice President, Research and Development since our inception in May 2001. Dr McAleer served as Vice President of Research and Development of our predecessor company, Inverness Medical Technology, from 1999 through November 2001, when that company was acquired by Johnson & Johnson. From 1995 to 1999, Dr. McAleer served as Director of Development of Inverness Medical Limited, Inverness Medical Technology's primary research and development unit, where he headed the development of Inverness Medical Technology's electrochemical glucose strips. Prior to joining Inverness Medical Technology, Dr. McAleer held senior research and development positions at MediSense from 1985 to 1993 and then at Ecossensors, Inc., an environmental research company, where he was responsible for the development of electrochemically based assay systems.

Norman Moore, Ph.D., received his doctorate in 1994 from the University of New Hampshire in Microbiology. He has been developing diagnostics throughout that time including FDA-approved tests for Influenza, RSV, Legionella, and S. pneumoniae. He is now the Director of Clinical Affairs at Inverness Medical Innovations.

Ellen Chiniara serves as General Counsel and Assistant Secretary and is responsible for managing legal matters for Inverness. Ms. Chiniara joined Inverness in October 2006 as General Counsel of the Professional Diagnostics strategic business unit and became General Counsel of the Company in May 2007. From 2002-2006, Ms. Chiniara was Associate General Counsel, Neurology of Serono, Inc., a biopharmaceutical company. Previously, she served as General Counsel to a healthcare venture capital fund and a healthcare management services organization, where she also was Chief Operating Officer of its clinical trial site management division. From 1994-1997, Ms. Chiniara was Assistant General Counsel at Value Health, a specialty managed healthcare company. She began her career as a corporate attorney in Boston with Hale and Dorr (now Wilmer Cutler Pickering Hale and Dorr LLP) where she gained extensive experience in venture capital, mergers and acquisitions, and high-growth companies. Ms. Chiniara has actively participated in PhRMA, BIO and has addressed industry groups regarding venture financing, HIPAA and bio-pharma joint ventures. Ms. Chiniara holds a juris doctorate from Stanford University and a bachelor's degree, magna cum laude from Bryn Mawr College.